v3.26.3
Acquisitions and Divestitures - Biolife, L.L.C (Details)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Apr. 01, 2026
USD ($)
item
May 16, 2025
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2026
USD ($)
Dec. 31, 2025
USD ($)
Biolife, L.L.C          
Business Acquisition [Line Items]          
Upfront payment   $ 120.0      
Working capital and other adjustments   $ 7.2      
Acquisition-related costs         $ 1.9
Weighted average useful life   12 years      
Biolife, L.L.C | Developed technology          
Business Acquisition [Line Items]          
Amortization period   12 years      
Biolife, L.L.C | Trademarks          
Business Acquisition [Line Items]          
Amortization period   12 years      
Biolife, L.L.C | Customer list          
Business Acquisition [Line Items]          
Amortization period   12 years      
View Point          
Business Acquisition [Line Items]          
Upfront payment $ 90.0        
Working capital and other adjustments $ 2.8        
Number of deferred payments | item 2        
Deferred annual payment $ 25.0        
Business Combination, Deferred Annual Payment Fair Value       $ 47.2  
Net sales related to acquisition     $ 0.1 0.1  
Acquisition-related costs       $ 5.7  
Weighted average useful life 12 years        
View Point | Developed technology          
Business Acquisition [Line Items]          
Amortization period 12 years        
View Point | Trademarks          
Business Acquisition [Line Items]          
Amortization period 12 years